Delivery Order SPE2DB22D1017-SPE2DB25FYPMM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,176.94 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness in...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count units) valued at $1,015.43 under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by August 13, 2025. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy and other sleep disorders. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,978.98 for SUNOSI 150 mg tablets (30-count) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a $1,881.03 delivery order to AmerisourceBergen Drug Corp for Sunosi 75 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- The Defense Logistics Agency awarded a delivery order valued at $3,058.44 to AmerisourceBergen Drug Corp for SUNOSI (sodium oxybate) 150 mg tablets in a quantity of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SUNOSI is a central...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Sunosi 75 mg tablets (30-count package) with a firm fixed price ceiling value of $3,765.50 and an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.77 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SUNOSI 150 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,372.38. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- This is a $3,157.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SUNOSI 150 MG TABLET 30S, a medication used to treat excessive daytime sleepiness. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPMMDelivery Order
The Defense Logistics Agency awarded a $2,769.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count) on August 29, 2025, with completion targeted for September 2, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. SUNOSI (solriamfetol) is a wakefulness-promoting agent primarily prescribed for narcolepsy and obstructive sleep apnea-related excessive daytime sleepiness, reflecting the pharmaceutical distributor's role in supplying specialized medications to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime pharmaceutical vendor contract enables AmerisourceBergen to supply a comprehensive range of medications and medical supplies globally to support Department of Defense health programs, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. As a major pharmaceutical distributor, AmerisourceBergen continues to serve as a critical vendor for federal medical procurement through competitively awarded contracts spanning diverse therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/29/25 |